Index
629
Aβpeptide, 513, 515, 516
ab initio calculations, 46
abacavir, 555
abortion, threatened spontaneous, 326
absolute configuration, 476
absorption, drug, 13
acarbose, 367, 369
accessory binding sites, receptor, 87
ACE inhibitors, 373–376, 380, 535
acedapsone, 579
acetazolamide, 495
acetohexamide, 367
acetylcholine, 33, 204–209, 486–491
metabolism, 206
receptors, 207
acetylcholinesterase, 484, 486–491
acetylcholinesterase inhibitors, 487–488
acetylsalicylic acid, 473, 484, 525
AChE, 486–491
acini, 360
acipimox, 320
acquired immune deficiency syndrome,
119, 554–556, 582
ACTH, 311, 315, 332, 346, 347–348
actin, 426
actinomycin D, 444, 445
action potential, 194–196
acute intermittent porphyria, 531
acyclovir, 18, 471, 552–553
adaptive immunity, 391
Addison’s disease, 336, 348
adenine nucleotide, 470
adenosine, 18
adenosine neuromodulators, 297, 298
adenosine triphosphatase, 492–494
adenylate cyclase, 484, 524
adenylate cyclase receptor system, 93–95
adhesion molecules, 392
ADME, 102, 146
adrenal cortex, 332
adrenal glands, 311
adrenal medulla, 332
adrenal steroids, 331–337
adrenal suppression, 336
adrenergic receptor, 218, 222–225
adrenocorticoids, 311, 312, 331–337, 474
adrenocorticotropic hormone, 311, 315, 332,
346, 347–348
adriamycin, 157
affinity, drug-receptor, 76
AFP, 516
agonist, 75, 76
partial, 76
AIP, 531
alanine scan, 114
β-alanine, 296, 297
albendazole, 588
albuterol, 232
alcohol metabolism, 150
aldehyde metabolism, 151
aldol reaction, 166, 172
aldose reductase inhibitors, 370
aldosterone, 337
alendronate, 536
aliphatic electrophilic substitution, 128
aliphatic nucleophilic substitution, 128
alkaloids, 480
alkane metabolism, 149
alkene epoxidation, 147
alkene metabolism, 150